combination glp-1 and sglt2 Effect of treatment with glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study SGLT2, GLP-1 RA Combination Therapy
Description
Discover how DMAE helps tighten and firm loose skin caused by GLP-1-related weight loss
Method We systematically searched PubMed and Embase from inception to 1 May 2025 for cohort studies comparing the effect of combination therapy with SGLT2 inhibitor or GLP-1 RA monotherapy on (cardiovascular) mortality and cardiovascular or kidney endpoints in individuals with type 2 diabetes
The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication
After 1 year, liraglutide/placebo recipients switched to liraglutide 2.4mg, then 3.0mg (based on 20-week and 1-year results, respectively)
What you need to know is covered in this article and infographic
